Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Carcinoma, Renal Cell"" wg kryterium: Temat


Tytuł :
Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.
Autorzy :
Sun G; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Chen J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Liang J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Yin X; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Zhang M; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Yao J; Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
He N; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd, Shanghai, China.
Armstrong CM; Department of Urology and Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.
Zheng L; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Zhang X; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Zhu S; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Sun X; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd, Shanghai, China.
Yang X; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd, Shanghai, China.
Zhao W; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd, Shanghai, China.
Liao B; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Pan X; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Nie L; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Yang L; Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Chen Y; Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Zhao J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Zhang H; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Dai J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Shen Y; Department of Oncology, West China Hospital, Sichuan University, Chengdu, China.
Liu J; Department of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Huang R; Department of Nuclear medicine, West China Hospital, Sichuan University, Chengdu, China.
Liu J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.; Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Wang Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Ni Y; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Wei Q; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Li X; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Zhou Q; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Huang H; Departments of Biochemistry and Molecular Biology and Urology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Liu Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. .
Shen P; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. .
Chen N; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. .
Zeng H; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Sep 06; Vol. 12 (1), pp. 5262. Date of Electronic Publication: 2021 Sep 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/*genetics
Carcinoma, Renal Cell/*genetics
Carcinoma, Renal Cell/*mortality
Kidney Neoplasms/*genetics
Kidney Neoplasms/*mortality
Adolescent ; Adult ; Aged ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/therapy ; Child ; Child, Preschool ; Female ; Gene Expression Regulation, Neoplastic ; Gene Fusion ; Humans ; Intracellular Signaling Peptides and Proteins/genetics ; Kidney Neoplasms/pathology ; Kidney Neoplasms/therapy ; Male ; Middle Aged ; Mutation ; Prognosis ; Sequence Analysis, RNA ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Whole Exome Sequencing ; Young Adult
Czasopismo naukowe
Tytuł :
The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
Autorzy :
Heyliger SO; Department of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, VA 23668, USA.
Soliman KFA; College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
Saulsbury MD; Department of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, VA 23668, USA.
Reams RR; College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
Pokaż więcej
Źródło :
Biomolecules [Biomolecules] 2021 Aug 12; Vol. 11 (8). Date of Electronic Publication: 2021 Aug 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Biomarkers, Tumor/*biosynthesis
Carcinoma, Renal Cell/*diagnosis
Carcinoma, Renal Cell/*metabolism
Kidney Neoplasms/*diagnosis
Kidney Neoplasms/*metabolism
Repressor Proteins/*biosynthesis
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/mortality ; Databases, Genetic/trends ; Female ; Humans ; Kidney Neoplasms/genetics ; Kidney Neoplasms/mortality ; Male ; Middle Aged ; Prognosis ; Repressor Proteins/genetics ; Survival Rate/trends ; Young Adult
Czasopismo naukowe
Tytuł :
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.
Autorzy :
Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK. .
Choueiri TK; Dana-Farber Cancer Center, Boston, MA, USA.
Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jonasch E; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pal S; City of Hope National Medical Center, Duarte, CA, USA.
Tannir NM; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Signoretti S; Brigham and Women's Hospital, Boston, MA, USA.
Kaldate R; Exelixis, Inc, Alameda, CA, USA.
Scheffold C; Exelixis, Inc, Alameda, CA, USA.
Wang E; Exelixis, Inc, Alameda, CA, USA.
Aftab DT; Exelixis, Inc, Alameda, CA, USA.
Escudier B; Gustave-Roussy, Villejuif, France.
George DJ; Duke Cancer Institute, Durham, NC, USA.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Aug 07; Vol. 21 (1), pp. 904. Date of Electronic Publication: 2021 Aug 07.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Anilides/*therapeutic use
Biomarkers, Tumor/*blood
Carcinoma, Renal Cell/*blood
Carcinoma, Renal Cell/*drug therapy
Everolimus/*therapeutic use
Kidney Neoplasms/*blood
Kidney Neoplasms/*drug therapy
Pyridines/*therapeutic use
Anilides/administration & dosage ; Anilides/adverse effects ; Carcinoma, Renal Cell/diagnosis ; Carcinoma, Renal Cell/mortality ; Everolimus/administration & dosage ; Everolimus/adverse effects ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/mortality ; Prognosis ; Pyridines/administration & dosage ; Pyridines/adverse effects ; Retreatment ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Chromophobe Renal Cell Carcinoma of a Renal Allograft.
Autorzy :
Saparbay J; Department of Hepatobiliary and Transplant Surgery, National Research Oncology Center, Nur-Sultan, Kazakhstan.
Assykbayev M; Department of Hepatobiliary and Transplant Surgery, National Research Oncology Center, Nur-Sultan, Kazakhstan.
Abdugafarov S; Department of Hepatobiliary and Transplant Surgery, National Research Oncology Center, Nur-Sultan, Kazakhstan.
Pokaż więcej
Źródło :
The American journal of case reports [Am J Case Rep] 2021 Oct 08; Vol. 22, pp. e933168. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnosis
Carcinoma, Renal Cell*/surgery
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/etiology
Kidney Neoplasms*/surgery
Kidney Transplantation*/adverse effects
Allografts ; Humans ; Kidney ; Neoplasm Recurrence, Local
Czasopismo naukowe
Tytuł :
Renal cell carcinoma with unusual metachronous metastasis up to 22 years after nephrectomy: two case reports.
Autorzy :
Bruckschen F; Department of Gastroenterology, Academic Teaching Hospital Bethesda Duisburg, Heerstr. 219, 47053, Duisburg, Germany.
Gerharz CD; Department of Pathology, Academic teaching Hospital Bethesda Duisburg, Heerstr. 219, 47053, Duisburg, Germany.
Sagir A; Department of Gastroenterology, Academic Teaching Hospital Bethesda Duisburg, Heerstr. 219, 47053, Duisburg, Germany. .
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2021 Oct 05; Vol. 15 (1), pp. 490. Date of Electronic Publication: 2021 Oct 05.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Aged ; Aged, 80 and over ; Humans ; Male ; Nephrectomy ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Clinical Significance of F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma.
Autorzy :
Betsunoh H; Department of Urology, Dokkyo Medical University, Mibu, Japan; .
Sakamoto S; Positron Emission Tomography Center, Dokkyo Medical University, Mibu, Japan.; Department of Radiology, Hyogo Cancer Center, Akashi, Japan.
Kaji Y; Department of Radiology, School of Medicine, Dokkyo Medical University, Mibu, Japan.
Nukui A; Department of Urology, Tochigi Cancer Center, Utsunomiya, Japan.
Kobayashi M; Department of Urology, Utsunomiya Memorial Hospital, Utsunomiya, Japan.
Yashi M; Department of Urology, Dokkyo Medical University, Mibu, Japan.
Hayashi K; Department of Pharmacology and Toxicology, School of Medicine, Dokkyo Medical University, Mibu, Japan.
Anzai N; Department of Pharmacology, Chiba University Graduate School of Medicine, Chiba, Japan.
Kamai T; Department of Urology, Dokkyo Medical University, Mibu, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 5179-5188.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Renal Cell/*pathology
Fluorodeoxyglucose F18/*metabolism
Glucose Transporter Type 1/*metabolism
Kidney Neoplasms/*pathology
Neoplasm Recurrence, Local/*pathology
Nephrectomy/*mortality
RNA, Messenger/*metabolism
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Renal Cell/diagnostic imaging ; Carcinoma, Renal Cell/metabolism ; Carcinoma, Renal Cell/surgery ; Female ; Follow-Up Studies ; Glucose Transporter Type 1/genetics ; Humans ; Kidney Neoplasms/diagnostic imaging ; Kidney Neoplasms/metabolism ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/surgery ; Positron Emission Tomography Computed Tomography/methods ; Prognosis ; RNA, Messenger/genetics ; Radiopharmaceuticals/metabolism ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Morphomics Can Predict Oncological Features and Survival of Metastatic Renal Cell Carcinoma After Cytoreductive Nephrectomy.
Autorzy :
Shao IH; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan, R.O.C.; Cancer Genome Research Center, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan, R.O.C.; Department of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.
Chang YH; Department of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.; Department of Urology, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital and Chang Gung University, New Taipei, Taiwan, R.O.C.
Sheng TW; Department of Medical Imaging and Intervention, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital and Chang Gung University, New Taipei, Taiwan, R.O.C.
Tan CC; Department of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.
Wang LJ; Department of Medical Imaging and Intervention, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital and Chang Gung University, New Taipei, Taiwan, R.O.C.
Chuang CK; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan, R.O.C.; Department of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.
Wu CT; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan, R.O.C.; .; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan, R.O.C.
Pang ST; Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan, R.O.C.; .; Department of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 5203-5211.
Typ publikacji :
Journal Article
MeSH Terms :
Body Composition*
Carcinoma, Renal Cell/*mortality
Cytoreduction Surgical Procedures/*mortality
Kidney Neoplasms/*mortality
Nephrectomy/*mortality
Adolescent ; Adult ; Aged ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/surgery ; Child ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel-Lindau protein ubiquitination and degradation.
Autorzy :
Yin R; Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Liu S; Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Oct; Vol. 112 (10), pp. 4100-4111. Date of Electronic Publication: 2021 Aug 22.
Typ publikacji :
Journal Article
MeSH Terms :
Basic Helix-Loop-Helix Transcription Factors/*metabolism
Carcinoma, Renal Cell/*etiology
Kidney Neoplasms/*etiology
Ubiquitins/*physiology
Von Hippel-Lindau Tumor Suppressor Protein/*metabolism
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/pathology ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Female ; Gene Silencing ; Heterografts ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/drug therapy ; Kidney Neoplasms/pathology ; Male ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Prognosis ; Protein Kinase Inhibitors/pharmacology ; Protein Processing, Post-Translational ; Proteolysis ; RNA, Small Interfering ; Random Allocation ; Sorafenib/pharmacology ; Ubiquitination ; Ubiquitins/genetics ; Ubiquitins/metabolism ; Up-Regulation
Czasopismo naukowe
Tytuł :
An unusual case of multiple bilateral kidney tumors.
Autorzy :
Hamroun A; Nephrology, Dialysis, and Kidney Transplantation Department, Lille University, Regional and University Hospital Center of Lille, 59000, Lille, France. .; Center for Research in Epidemiology and Population Health (CESP), Clinical Epidemiology Team, National Institute of Health and Medical Research, Villejuif, France. .
Lenain R; Nephrology, Dialysis, and Kidney Transplantation Department, Lille University, Regional and University Hospital Center of Lille, 59000, Lille, France.
Provôt F; Nephrology, Dialysis, and Kidney Transplantation Department, Lille University, Regional and University Hospital Center of Lille, 59000, Lille, France.
Maanaoui M; Nephrology, Dialysis, and Kidney Transplantation Department, Lille University, Regional and University Hospital Center of Lille, 59000, Lille, France.; INSERM U1190, Translational Research for Diabetes, Lille, France.
Lionet A; Nephrology, Dialysis, and Kidney Transplantation Department, Lille University, Regional and University Hospital Center of Lille, 59000, Lille, France.
Pokaż więcej
Źródło :
Journal of nephrology [J Nephrol] 2021 Oct; Vol. 34 (5), pp. 1783-1784. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Humans
Czasopismo naukowe
Tytuł :
Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.
Autorzy :
Purdue MP; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Rhee J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Moore L; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gao X; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Sun X; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kirk E; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Bencko V; First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
Janout V; Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
Mates D; Department of Environmental Health, Institute of Public Health, Bucharest, Romania.
Zaridze D; Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russia.
Petruzella S; Departments of Surgery and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Hakimi AA; Departments of Surgery and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Linehan WM; Department of Health and Human Services, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Brennan P; Section of Genetics, International Agency for Research on Cancer, Lyon, France.
Furberg H; Departments of Surgery and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Troester M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Rothman N; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 01; Vol. 149 (7), pp. 1448-1454. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Renal Cell/*pathology
Kidney Neoplasms/*pathology
Aged ; Carcinoma, Renal Cell/classification ; Carcinoma, Renal Cell/etiology ; Case-Control Studies ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/classification ; Kidney Neoplasms/etiology ; Male ; Meta-Analysis as Topic ; Middle Aged ; Prognosis ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
Autorzy :
Aggarwal RK; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Luchtel RA; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Machha V; InBios International Inc., Seattle, WA 98109.
Tischer A; Department of Medicine (Hematology), Mayo Clinic, Rochester, MN 55905.
Zou Y; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Pradhan K; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Ashai N; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Ramachandra N; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Albanese JM; Department of Pathology, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Yang JI; Department of Medicine, Albert Einstein College of Medicine-Jacobi Medical Center, Bronx, NY 10461.
Wang X; Department of Medicine, Albert Einstein College of Medicine-Jacobi Medical Center, Bronx, NY 10461.
Aluri S; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Gordon S; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Aboumohamed A; Department of Urology, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Gartrell BA; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.; Department of Urology, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Hafizi S; Department of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2UP, United Kingdom.
Pullman J; Department of Pathology, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461.
Shenoy N; Department of Medicine (Oncology), Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY 10461; .; Experimental Therapeutics Program, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461.; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Sep 28; Vol. 118 (39).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Methylation*
Epigenesis, Genetic*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Carcinoma, Renal Cell/*pathology
Kidney Neoplasms/*pathology
Succinate Dehydrogenase/*metabolism
5-Methylcytosine/chemistry ; Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/metabolism ; Cell Cycle ; Cell Movement ; Cell Proliferation ; Humans ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; Mutation ; Neoplasm Invasiveness ; Prognosis ; Succinate Dehydrogenase/genetics ; Survival Rate ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
A rare association in a patient with non-muscle invasive bladder cancer: ureteral fibroepithelial polyp and ipsilateral renal cell carcinoma: a case report.
Autorzy :
Akan S; Department of Urology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey. .
Ediz C; Department of Urology, University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, Tr- 34668, Istanbul, Turkey.
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2021 Sep 26; Vol. 15 (1), pp. 475. Date of Electronic Publication: 2021 Sep 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/pathology
Carcinoma, Renal Cell*/surgery
Carcinoma, Transitional Cell*/diagnostic imaging
Carcinoma, Transitional Cell*/pathology
Carcinoma, Transitional Cell*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/pathology
Kidney Neoplasms*/surgery
Polyps*/diagnostic imaging
Polyps*/surgery
Ureter*/diagnostic imaging
Ureter*/pathology
Ureter*/surgery
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Cross-Sectional Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł :
Hereditary leiomyomatosis associated with renal cell carcinoma.
Autorzy :
Pérez-López I; Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario San Cecilio. Granada, España. Electronic address: .
Ródenas-Herranz T; Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario San Cecilio. Granada, España.
Ruiz-Villaverde R; Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario San Cecilio. Granada, España.
Pokaż więcej
Transliterated Title :
Leiomiomatosis hereditaria asociada al carcinoma de células renales.
Źródło :
Medicina clinica [Med Clin (Barc)] 2021 Sep 24; Vol. 157 (6), pp. 307. Date of Electronic Publication: 2020 Aug 15.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma, Renal Cell*/diagnosis
Carcinoma, Renal Cell*/genetics
Kidney Neoplasms*/genetics
Leiomyomatosis*/diagnosis
Leiomyomatosis*/genetics
Neoplastic Syndromes, Hereditary*/diagnosis
Neoplastic Syndromes, Hereditary*/genetics
Humans
Opinia redakcyjna
Tytuł :
Esophageal metastasis of renal cell carcinoma resected by endoscopic submucosal dissection: a case report.
Autorzy :
Ohnita K; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan. .; Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, Japan. .
Higashi S; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan.
Hirai S; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan.
Kuwahara A; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan.
Kakigao K; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan.
Nakashiki S; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan.
Inoue K; Department of Gastroenterology and Hepatology, Shunkaikai Inoue Hospital, 6-12 Takara-machi, Nagasaki, Japan.
Kurohama H; Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
Nakashima M; Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
Nakao K; Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, Japan.
Pokaż więcej
Źródło :
BMC gastroenterology [BMC Gastroenterol] 2021 Sep 20; Vol. 21 (1), pp. 348. Date of Electronic Publication: 2021 Sep 20.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/surgery
Endoscopic Mucosal Resection*
Esophageal Neoplasms*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Splenic Neoplasms*
Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study.
Autorzy :
Erman M; Medical Oncology, Hacettepe University, Ankara, Turkey.
Biswas B; Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Danchaivijitr P; Medical Oncology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chen L; Medical Oncology, The First Affiliated Hospital of Sun Yat-sen, Guangzhou, Guangdong Province, China.
Wong YF; Radiotherapy and Oncology, National Cancer Institute, Putrajaya, Malaysia.
Hashem T; Medical Oncology, Dr Tarek Hashem's Clinic, Cairo, Egypt.
Lim CS; Clinical Oncology, Sultan Ismail Hospital, Johor Bahru, Malaysia.
Karabulut B; Medical Oncology, Ege University, Izmir, Turkey.
Chung HJ; Department of Urology, Taipei Veterans General Hospital and Department of Urology, College of Medicine and Shu-Tien Urological Research Cente, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chikatapu C; Oncology, Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India.
Ingles S; Oncology, Novartis Pharma AG, Basel, Switzerland.
Slimane K; Oncology, Novartis Pharma SAS, Rueil-Malmaison, France.
Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Sep 14; Vol. 21 (1), pp. 1021. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Observational Study
MeSH Terms :
Angiogenesis Inhibitors/*therapeutic use
Antineoplastic Agents/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Indazoles/*therapeutic use
Kidney Neoplasms/*drug therapy
Pyrimidines/*therapeutic use
Sulfonamides/*therapeutic use
Adult ; Africa, Northern ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Angiogenesis Inhibitors/adverse effects ; Asia ; Carcinoma, Renal Cell/ethnology ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Female ; Humans ; Indazoles/administration & dosage ; Indazoles/adverse effects ; Kidney Neoplasms/ethnology ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Middle East ; Progression-Free Survival ; Prospective Studies ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Response Evaluation Criteria in Solid Tumors ; Risk Factors ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Renal Cell Carcinoma Mimicking Transitional Cell Carcinoma: A Case Report.
Autorzy :
Irama W; Department of Diagnostic Radiology, Changi General Hospital, Singapore, Singapore.; Department of Radiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Teo JK; Department of Urology, Changi General Hospital, Singapore (Yong Loo Lin School of Medicine, NUS), Singapore, Singapore.
Wong KM; Department of Diagnostic Radiology, Changi General Hospital, Singapore (Duke-NUS Medical School), Singapore, Singapore.
Pokaż więcej
Źródło :
The American journal of case reports [Am J Case Rep] 2021 Sep 06; Vol. 22, pp. e932098. Date of Electronic Publication: 2021 Sep 06.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnosis
Carcinoma, Renal Cell*/surgery
Carcinoma, Transitional Cell*/diagnosis
Carcinoma, Transitional Cell*/surgery
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/surgery
Aged ; Female ; Humans ; Neoplasm Recurrence, Local ; Nephrectomy
Czasopismo naukowe
Tytuł :
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
Autorzy :
Qi X; Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Lv X; Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Wang X; Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Ruan Z; The Nursing College of Zhengzhou University, Zhengzhou 450052, China.
Zhang P; Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, China.
Wang Q; Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Xu Y; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
Wu G; Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2021 Sep 02; Vol. 2021, pp. 9972968. Date of Electronic Publication: 2021 Sep 02 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Renal Cell/*genetics
Carcinoma, Renal Cell/*pathology
Cholesterol/*genetics
Biomarkers, Tumor/genetics ; Carcinoma, Renal Cell/mortality ; China ; Cholesterol/biosynthesis ; Databases, Genetic ; Gene Expression/genetics ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Kaplan-Meier Estimate ; Kidney/pathology ; Kidney Neoplasms/genetics ; Kidney Neoplasms/pathology ; Nomograms ; Prognosis ; Proportional Hazards Models ; ROC Curve ; Risk Factors ; Transcriptome/genetics
Czasopismo naukowe
Tytuł :
Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus.
Autorzy :
Colli LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA; Department of Medical Imaging, Hematology, and Oncology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP 14040-900, Brazil.
Jessop L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Myers TA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Camp SY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Choi J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Cunha R; Department of Medical Imaging, Hematology, and Oncology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP 14040-900, Brazil; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Onabajo O; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Mills GC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Schmid V; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK.
Brodie SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris 75248, France.
Mole DR; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK.
Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Brown KM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA. Electronic address: .
Pokaż więcej
Źródło :
American journal of human genetics [Am J Hum Genet] 2021 Sep 02; Vol. 108 (9), pp. 1590-1610. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :
Chromosomes, Human, Pair 14*
Genetic Loci*
Carcinoma, Renal Cell/*genetics
DNA-Binding Proteins/*genetics
Kidney Neoplasms/*genetics
STAT3 Transcription Factor/*genetics
Transcription Factors/*genetics
Carcinogenesis/genetics ; Carcinogenesis/immunology ; Carcinogenesis/pathology ; Carcinoma, Renal Cell/immunology ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/therapy ; Cell Line, Tumor ; Chromatin/chemistry ; Chromatin/immunology ; Chromatin Assembly and Disassembly/immunology ; Cytokines/genetics ; Cytokines/immunology ; DNA-Binding Proteins/immunology ; Gene Expression Regulation ; Genetic Predisposition to Disease ; Genome, Human ; Genome-Wide Association Study ; High-Throughput Nucleotide Sequencing ; Humans ; Immunotherapy/methods ; Kidney Neoplasms/immunology ; Kidney Neoplasms/pathology ; Kidney Neoplasms/therapy ; Polymorphism, Single Nucleotide ; STAT3 Transcription Factor/immunology ; T-Lymphocytes, Cytotoxic ; Transcription Factors/immunology
Czasopismo naukowe
Tytuł :
Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.
Autorzy :
De Marini P; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France. Electronic address: .
Cazzato RL; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Garnon J; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Dalili D; School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, United Kingdom.
Leonard-Lorant I; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Leclerc L; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Autrusseau PA; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Auloge P; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Weiss J; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Tricard T; Department of Urology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Lang H; Department of Urology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France.
Gangi A; Department of Interventional Radiology, University Hospital of Strasbourg, 67091 Strasbourg cedex, France; School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, United Kingdom.
Pokaż więcej
Źródło :
Diagnostic and interventional imaging [Diagn Interv Imaging] 2021 Sep; Vol. 102 (9), pp. 531-538. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/surgery
Cryosurgery*
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC).
Autorzy :
Pesta M; Department of Biology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.
Travnicek I; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic.
Kulda V; Department of Medical Chemistry and Biochemistry, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; .
Windrichova J; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.; Department of Medical Chemistry and Biochemistry, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Rezackova H; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.
Houfkova K; Department of Biology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Macanova T; Department of Biology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Bendova B; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic.
Nestorova A; Department of Medical Chemistry and Biochemistry, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Hes O; Department of Pathology, University Hospital in Pilsen, Pilsen, Czech Republic.
Hora M; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic.
Topolcan O; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.
Polivka J; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.; Department of Histology and Embryology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Sep; Vol. 41 (9), pp. 4463-4470.
Typ publikacji :
Journal Article
MeSH Terms :
Up-Regulation*
Angiogenic Proteins/*genetics
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Gene Expression Profiling/*methods
Kidney Neoplasms/*genetics
Receptors, G-Protein-Coupled/*genetics
Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/surgery ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kidney Neoplasms/mortality ; Kidney Neoplasms/surgery ; Male ; Oligonucleotide Array Sequence Analysis ; Prognosis ; Regression Analysis ; Survival Analysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies